We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Gilead to Launch Generics for Its Hepatitis C Drugs
Gilead to Launch Generics for Its Hepatitis C Drugs
Against a backdrop of declining sales for its branded hepatitis drugs, Gilead announced plans to launch its own “authorized generics” of two of its hep C treatments.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor
